Should women with diabetic nephropathy considering pregnancy continue ACE inhibitor or angiotensin II receptor blocker therapy until pregnancy is confirmed?

Diabetologia

Volumn 57, Issue 5, 2014, Pages 1082-1083

  Lewis, Gareth ^a   Maxwell, Alexander P ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

ACE inhibitor; Angiotensin II receptor blocker; Clinical diabetes; Hypertension; Nephropathy; Pregnancy

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C;

ADVERSE OUTCOME; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; CONGENITAL MALFORMATION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; FEMALE; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; GLYCEMIC CONTROL; HIGH RISK PREGNANCY; HUMAN; HYPERTENSION; KIDNEY FAILURE; LETTER; MATERNAL AGE; MATERNAL CARE; OBESITY; OUTCOMES RESEARCH; PATIENT COUNSELING; PREECLAMPSIA; PREGNANCY; PREMATURITY; PRENATAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SMALL FOR DATE INFANT; TREATMENT OUTCOME; COMPLICATION; CONGENITAL ABNORMALITIES; EPIDEMIOLOGY; FETUS DEATH; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREGNANCY DIABETES MELLITUS; PROCEDURES; STILLBIRTH;

CONGENITAL ABNORMALITIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; FETAL DEATH; HUMANS; PRECONCEPTION CARE; PREGNANCY; PREGNANCY IN DIABETICS; STILLBIRTH;

EID: 84898600169     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3188-x     Document Type: Letter

References (8)

1. Tennant PWG, Glinianaia SV, Bilous RW, Rankin J, Bell R (2014) Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study. Diabetologia 57:285-294
2. Bullo M, Tschumi S, Bucher BS, Bianchetti MG, Simonetti GD (2012) Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review. Hypertension 60:444-450
3. Cooper WO, Hernandez-Diaz S, Arbogast PG et al (2006) Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 354:2443-2451 (Pubitemid 43855047)
4. Polifka JE (2012) Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence. Birth Defects Res A Clin Mol Teratol 94:576-598
5. Porta M, Hainer JW, Jansson SO et al (2011) Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled diabetic retinopahty candesartan trials. Diabetologia 54:1298-1303
6. Mathiesen EM, Ringholm L, Feldt-Rasmussen B, Clausen P, Damm P (2012) Obstetric nephrology: pregnancy in women with diabetic nephropathy - the role of antihypertensive treatment. Clin J Am Soc Nephrol 7:2081-2088
7. Nielsen LR, Damm P, Mathiesen ER (2009) Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy? Diabetes Care 32:38-44
8. Bar J, Chen R, Schoenfeld A et al (1999) Pregnancy outcome in patients with insulin dependent diabetes mellitus and diabetic nephropathy treated with ACE inhibitors before pregnancy. J Pediatr Endocrinol Metab 12:659-665 (Pubitemid 29422062)